Terlipressin Impurity 30 CAS CATO-C4X-219330
| CAS No. | CATO-C4X-219330 |
| Molecular Formula | C104H148N32O30S4 |
| Molecular Weight | 2454.74 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Terlipressin Impurity 30 is closely related to a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
CATO supplies Terlipressin Impurity 30 (CAS CATO-C4X-219330), a pharmacopoeial impurity reference standard (molecular formula C104H148N32O30S4, MW 2454.74 g/mol) used for the identification and quantification of trace impurities in APIs.
The molecular framework of Terlipressin Impurity 30 (C104H148N32O30S4) is characterized by a nitrogen-containing heterocyclic scaffold, an amide group, a sulfone group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the protonation state of its nitrogen-containing groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
As a certified reference material (CRM), Terlipressin Impurity 30 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C104H148N32O30S4 |
| Molecular Weight | 2454.74 g/mol |
| Purity | 97%+ |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening |
| Degree of Unsaturation (DBE) | 47.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Nitrogen Atoms | 32 |
| Sulfur Atoms | 4 |
Related Terlipressin Standards
- Terlipressin Impurity 29 (CAS CATO-C4X-219329)
- Terlipressin Impurity 19 X TFA Salt (CAS CATO-C4X-219319)
- Terlipressin Impurity 20 X TFA Salt (CAS CATO-C4X-219320)
- Terlipressin Impurity 21 X TFA Salt (CAS CATO-C4X-219321)
- Terlipressin Impurity 22 X TFA Salt (CAS CATO-C4X-219322)
- Terlipressin Impurity 23 (CAS CATO-C4X-219323)
- Terlipressin Impurity 38 (CAS CATO-C4X-219338)
- Terlipressin Impurity 26 X TFA Salt (CAS CATO-C4X-219326)
Recommended Standards
- H-Glu-Leu-Asp-[(2R,4S,5S)-5-amino-4-hydroxy-2,7-dimethyl-octanoyl]-Val-Glu-Phe-Gly-Gly-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-D-Arg-OH (N-1920.0500) (CAS 527674-72-2)
- Tertiapin-Q (CAS 910044-56-3)
- [(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl] N-[2-[[4-[[(2S)-2-[[(2S)-2-[2-[2-[2-[[(1R,8S)-9-bicyclo[6.1.0]non-4-ynyl]methoxycarbonylsulfamoylamino]ethoxy]ethoxycarbonylsulfamoyl-[2-[[(1S)-1-[[(1S)-1-[[4-[[2-[[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²¹¹.0⁴⁹.0¹⁵²º]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-7-yl]oxycarbonyl-methyl-amino]ethyl-methyl-carbamoyl]oxymethyl]phenyl]carbamoyl]-4-ureido-butyl]carbamoyl]-2-methyl-propyl]carbamoyloxy]ethyl]amino]ethoxycarbonylamino]-3-methyl-butanoyl]amino]-5-ureido-pentanoyl]amino]phenyl]methoxycarbonyl-methyl-amino]ethyl]-N-methyl-carbamate (CAS 2765424-54-0)
- Bis[2-(4-aminophenyl)ethynyl]tetrakis[1,1′-(1,2-ethanediyl)bis[1,1-diphenylphosphine-κP]][μ-[(3,3,4,4,5,5-hexafluoro-1-cyclopentene-1,2-diyl)bis[(5-methyl-4,2-thiophenediyl)-2,1-ethynediyl]]]di-Ruthenium (CAS 2130962-92-2)
- Mirtazapine Impurity 25 (CAS CATO-C4X-151125)
- Lansoprazole Impurity 29 (CAS 163119-28-6)
- Resmetirom impurity 86 (CAS CATO-C4X-291286)
- 3-((3-Methylpiperidin-1-yl)methyl)benzenethiol (CAS 1443339-15-8)
- [2-(2-chloroethoxy)ethyl]dimethylamine hydrochloride (CAS 878788-47-7)
- 4-(4-Nitro-2H-1,2,3-triazol-2-yl)-1,2,5-oxadiazol-3-amine (CAS 890094-07-2)
- (3-Amino-1H-1,2,4-triazol-5-yl)(piperidin-1-yl)methanone (CAS 294853-92-2)
- Bromoferrocene (CAS 1273-73-0)
- sodium 2-amino-3,3,3-trifluoro-2-(1H-pyrrol-2-yl)propanoate (CAS 1909327-31-6)
- Anti-TF Antigen Peptide P30-1 trifluoroacetate salt (CAS 573664-50-3)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com